We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC CONCERTA FACES DELAY BY McNEIL'S CITIZEN PETITION
GENERIC CONCERTA FACES DELAY BY McNEIL'S CITIZEN PETITION
April 6, 2004
Andrx’s plans to market a version of McNeil Consumer & Specialty Pharmaceuticals’ attention deficit/hyperactivity disorder (ADHD) drug Concerta could face new hurdles if the FDA accepts McNeil’s argument that additional studies are needed to establish bioequivalency.